| Hans-Günter Meyer-Thompson | Hepatitiden
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
Valencia La Rosa J, Ryan P, Alvaro-Meca A, Troya J, Cuevas G, Gutiérrez J, et al. (2018)
PLoS ONE 13(10): e0204795. doi.org/10.1371/journal.pone.0204795
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0204795